UBS Group AG Registered Ordinary Shares (UBS)

Shares of healthcare insurance company Molina Healthcare (NYSE:MOH) fell 3.8% in the afternoon session after TD Cowen lowered its price target on the stock to $283 from $369, citing elevated medical costs. 

Shares of online marketplace Etsy (NASDAQ:ETSY) jumped 3.1% in the pre-market session after the company received positive attention from Wall Street analysts, including an upgrade from Morgan Stanley and a price target increase from UBS. 

Retail investor engagement surged on Stocktwits, with messages jumping over 900% in 24 hours following the upbeat Q2 earnings.

Shares of health insurance company Oscar Health (NYSE:OSCR) fell 3.1% in the morning session after the stock continued a sharp decline from the previous session, which was fueled by multiple analyst downgrades and broader weakness in the healthcare plans sector. 

Wall Street analysts see renewed strength in Unity Software, citing improved ad performance, rising sentiment, and product upgrades.

All of a sudden, everyone on Wall Street loves Unity Software stock.

UBS expects the US economy to slow significantly in 2025, projecting real GDP growth to fall to around 1%.

The food and beverage giant has been under pressure for several quarters, weighed down by shifting consumer preferences toward healthier options, stiff competition, and broader weakness in consumer spending.

Apple is aiming to release its first folding-screen iPhone in late 2026, a Wall Street stock analyst says. Rival Samsung is years ahead.

Index trends show that consumer discretionary stocks gained marginally, while consumer staple stocks declined.

Several Wall Street analysts have upwardly revised their year-end targets for the S&P 500 in recent weeks.

Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) fell 3.5% in the afternoon session after a cautious analyst note from UBS highlighting significant upcoming expenses and other headwinds. Ahead of its second-quarter earnings report, UBS reiterated its "Neutral" rating on the stock. The firm's note pointed to several challenges, including an expected $1.5 billion expense for in-process research and development (IPR&D) related to a collaboration with BioNTech. This charge is anticipated to reduce the company's earnings per share (EPS) by approximately $0.60. The report also touched on broader investor concerns, such as the impact of Medicare's Part D redesign on several of the company's high-priced drugs and the looming patent expirations for key products. These factors contribute to a more cautious outlook on the pharmaceutical giant's near-term profitability and growth prospects. 

Vertiv stock rose Friday after plunging Thursday on a report that AWS had developed a possible competing liquid-cooling system.

Many investors have soured on this former market darling, but that may be a "go" sign for new buyers in light of its quiet and underappreciated progress on the AI front.

Analysts flag crucial support levels between 25,100 and 25,200.

Avenue Supermarts (DMart), and Aditya Birla Money, among companies to report Q1 results later in the day

Hunterbrook Media cited UBS saying that if Amazon automates up to 80% of the 14 billion items it handles annually with its new robot, it could generate an estimated $400 million in revenue for Teradyne.

MercadoLibre stock was down more than 3% in Thursday trading after Trump threatened a 50% tariff on Brazil, MercadoLibre's largest market.

In a recent interview, UBS Group AG CEO Sergio Ermotti expressed optimism about the U.S. market, despite ongoing tariff uncertainties.

According to Fiscal.ai data, analysts expect the company to post second-quarter EPS of $2.05 on revenue of $16.18 billion.

Texas Instruments stock is approaching a buy point ahead of the chipmaker's second-quarter earnings report.